We have previously shown that microinjection of monoclonal antibody to atrial natriuretic peptide (ANP) into the caudal nucleus tractus solitarii causes a pressor response in salt-sensitive spontaneously hypertensive rats (SHR) fed a basal (1%) salt diet, suggesting that endogenous ANP in this region may be involved in the centrally mediated regulation of blood pressure in this model. The present study tested the hypothesis that the pressor effect of blocking endogenous ANP in caudal nucleus tractus solitarii is enhanced by dietary salt supplementation in salt-sensitive SHR. Monoclonal antibody to ANP (0.55 /ig) in 50 nl artificial cerebrospinal fluid or control immunoglobulin G was microinjected into the caudal nucleus tractus solitarii of conscious salt-sensitive SHR, salt-resistant SHR, and Wistar-Kyoto rats fed 1% or 8% salt diets for 3 weeks. Microinjection of the monoclonal antibody into the caudal nucleus tractus solitarii evoked similar increases in mean arterial pressure hi salt-sensitive SHR on both 1% and 8% salt diets and in salt-resistant SHR on a 1% salt diet but had no effect in Wistar-Kyoto rats. In contrast, microinjection of control immunoglobulin G into this brain area did not alter mean arterial pressure or heart rate in any experimental group. Thus, endogenous ANP in caudal nucleus tractus solitarii mediates tonic control of blood pressure in both salt-sensitive and sail-resistant SHR hut not in Wistar-Kyoto rats, and this effect is independent of the salt sensitivity of hypertension and of dietary salt intake. (Hypertension 1992^0:242-246) 
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We have previously shown that microinjection of monoclonal antibody to atrial natriuretic peptide (ANP) into the caudal nucleus tractus solitarii causes a pressor response in salt-sensitive spontaneously hypertensive rats (SHR) fed a basal (1%) salt diet, suggesting that endogenous ANP in this region may be involved in the centrally mediated regulation of blood pressure in this model. The present study tested the hypothesis that the pressor effect of blocking endogenous ANP in caudal nucleus tractus solitarii is enhanced by dietary salt supplementation in salt-sensitive SHR. Monoclonal antibody to ANP (0.55 /ig) in 50 nl artificial cerebrospinal fluid or control immunoglobulin G was microinjected into the caudal nucleus tractus solitarii of conscious salt-sensitive SHR, salt-resistant SHR, and Wistar-Kyoto rats fed 1% or 8% salt diets for 3 weeks. Microinjection of the monoclonal antibody into the caudal nucleus tractus solitarii evoked similar increases in mean arterial pressure hi salt-sensitive SHR on both 1% and 8% salt diets and in salt-resistant SHR on a 1% salt diet but had no effect in Wistar-Kyoto rats. In contrast, microinjection of control immunoglobulin G into this brain area did not alter mean arterial pressure or heart rate in any experimental group. Thus, endogenous ANP in caudal nucleus tractus solitarii mediates tonic control of blood pressure in both salt-sensitive and sail-resistant SHR hut not in Wistar-Kyoto rats, and this effect is independent of the salt sensitivity of hypertension and of dietary salt intake. salt-sensitive spontaneously hypertensive rats (SHR-S) from Taconic Farms (IBU3 colony, Germantown, N.Y.) exhibit significant increases in blood pressure and sympathetic outflow when fed a high-NaCl diet.
1 " 3 In contrast, salt-resistant SHR (SHR-R) from Charles River Breeding Laboratories (Kingston, N.Y.) and nonnotensive control WistarKyoto (WKY) rats do not develop these changes in blood pressure and sympathetic nervous system activity in response to dietary NaCl supplementation. We recently demonstrated that microinjection of monoclonal antibody (MAb) to atrial natriuretic peptide (ANP) into the caudal nucleus tractus solitarii (C-NTS) produces significant increases in blood pressure in SHR-S fed basal (1%) NaCl diets but not in WKY rats. 4 Control injection of an equal volume of immunoglobulin G (IgG) into the C-NTS had no effect on blood pressure in SHR-S. Furthermore, control microinjection of the MAb into the hypoglossal nucleus, spinal trigeminal nucleus, or cuneate nucleus did not significantly alter blood pressure in either strain. These data suggest that endogenous ANP in C-NTS may be involved in the centrally mediated regulation of blood pressure in SHR-S.
Our laboratory has previously shown that arterial and cardiopulmonary baroreceptor reflex-mediated control of lumbar sympathetic nerve activity in SHR-S maintained on a basal NaCl diet is impaired. SHR-S maintained on a 1% NaCl diet have blunted baroreceptor reflex control of lumbar sympathetic nerve activity during acute increases or decreases in mean arterial pressure (MAP) and during acute plasma volume expansion compared with SHR-R, WKY, and Sprague-Dawley rats.
5 -7 Furthermore, we have observed that high dietary NaCl exposure enhances arterial baroreceptor reflex control of lumbar sympathetic nerve activity in SHR-S during phenylephrine-induced increases in MAP. 7 In contrast, high dietary NaCl exposure exacerbates the impairment in lumbar sympathetic nerve activity responses to acute volume expansion in SHR-S (unpublished observation). The finding of further blunting of an already impaired cardiopulmonary baroreceptor reflex in SHR-S during dietary NaCl supplementation is consistent with the observed inability of NaCl-sensitive hypertensive subjects to reduce sympathetic nervous system activity appropriately in response to volume expansion.
Because the C-NTS plays an important role in baroreceptor reflex-mediated control of blood pressure and sympathetic outflow, both of which are sensitive to dietary NaCl intake in the SHR model, the present study was designed to test whether the pressor effect of blocking endogenous ANP in the C-NTS with MAb is affected by dietary NaCl supplementation in SHR-S. We studied SHR-S on 1% and 8% NaCl diets, SHR-R on a 1% NaCl diet, and WKY rats on 1% and 8% NaCl diets. Microinjection of IgG purified from mouse ascites fluid into the C-NTS served as a vehicle control. We found that blockade of endogenous ANP in the C-NTS increased blood pressure to the same extent in SHR-S fed 1% and 8% NaCl diets and in SHR-R fed the 1% NaCl diet but had no effect in WKY rats on either diet. Thus, endogenous ANP in the C-NTS mediates tonic control of blood pressure in both SHR-S and SHR-R but not in WKY rats, and this effect is independent of the NaCl sensitivity of hypertension and of dietary NaCl intake.
Methods
Male SHR-S and normotensive WKY control rats were obtained from Taconic Farms (IBU-3 colony, Germantown, N.Y.) at 7 weeks of age. Male SHR-R were obtained from Charles River Breeding Laboratories (Kingston, N.Y.) at the same age. All rats were maintained four per cage at constant humidity (65±5%), temperature (24±1°C), and light cycle (6 AM-6 PM). Three days after arrival, one half of the SHR-S and WKY rats were placed at random on an 8% NaCl diet (ICN Biochemicals Purina Chow with 8% NaCl, Costa Mesa, Calif.), and the other half remained on the 1% NaCl diet (Ralston-Purina Diet 5001, St. Louis, Mo.). SHR-R were placed on the 1% NaCl diet. Food and water were available ad libitum throughout the study.
Nineteen days after initiation of the special diets, each rat was anesthetized with sodium pentobarbital (50 mg/kg i.p.), and a cannula (polyethylene PE-10 fused with PE-50) was implanted into the abdominal aorta through the right femoral artery. The rat was then placed into a stereotaxic apparatus, the skin overlying the middle of the skull was incised, and a small hole was drilled through the appropriate portion of the skull. A guide cannula (26-gauge stainless steel tubing) was lowered to a position 2.0 mm dorsal to the C-NTS (anterior/posterior, 4.8-5.1 mm from the interaural line; medial/lateral, 0.5 mm; dorsal/ventral, 8.5 mm; incisor bar, 4.5 mm). The guide cannula was fixed to the skull with stainless steel screws and fast polymerized cannula cement. A 32-gauge obturator (stainless steel wire) was inserted into the guide cannula after implantation.
Forty-eight hours after surgery, the arterial catheter was connected to a model CP-01 pressure transducer (Century Technology Co., Inglewood, Calif.) coupled to a polygraph (Model 7, Grass Instruments, Quincy, Mass.). MAP and heart rate (HR) were measured simultaneously. After a 45-minute stabilization period, the obturator was removed from the guide cannula and replaced with an inner cannula (32-gauge stainless steel tubing) filled with the agent to be administered. The tip of the inner cannula extended 2 mm beyond the guide cannula. The inner cannula was attached to a 0.5 -/xl At the conclusion of each experiment, 1% methylene blue solution (50 nl) was injected through the cannula. The rat was anesthetized with sodium pentobarbital (60 mg/kg i.p.) and decapitated, and the cannula was removed from the brain. The brain was removed from the skull and sectioned at 30 ^tm on a freezing microtome (Slee Medical Equipment Ltd., London). Sections were mounted and stained with 1% thionine for verification of the microinjection site and for measurement of extent of spread of the dye.
The MAb used in these studies was the high-affinity antibody against rat a-ANP, the 28-amino acid form of ANP, produced by Mukoyama et al 8 and named MAb KY-ANP-II. MAb KY-ANP-II recognizes human ANP (a-h ANP) and rat ANP (o-r ANP) equally and blocks the ability of both exogenous and endogenous ANP to elevate plasma cyclic GMP (cGMP) levels. 9 Furthermore, elevated plasma cGMP levels in stroke-prone SHR (SHRSP) and deoxycorticosterone acetate-salthypertensive rats were significantly reduced by intravenous administration of MAb KY-ANP-II, indicating that the antibody can block the activity of a-x ANP in the intact rat. We purified IgG containing MAb KY-ANP-II from mouse ascites fluid (1 ml) using a protein A agarose column. 10 Retained IgG with MAb KY-ANP-II was eluted from the protein A column with 3 M MgCl and dialyzed against 0.9% saline overnight. We demonstrated that the purified IgG (1.1 mg/ml) with MAb KY-ANP-II bound 50% of l2 I-ANP (17,000 cpm) at 1:100,000 final dilution in a total volume of 500 /tl.
11
In addition, we observed that intravenous injection of a 100-Mg dose of purified MAb KY-ANP-II inhibited the increase in plasma cGMP induced by exogenous ANP (20 Mg/kg i.v.) in the intact rat, 12 confirming the previous characterization of Itoh et al. 9 The dose of MAb KY-ANP-II (0.55 fig) administered in the present study is equivalent to the amount of anti-ANP antibody contained in 0.55 ^,1 of mouse ascites fluid, 0.5% of the peripheral intravenous dose (100 fil of ascites fluid) of this MAb used in previous studies by Itoh et al. 9 
Statistical Analysis
Results are expressed as mean±SEM. Analysis of variance (ANOVA) was performed to assess the differences in MAP and HR responses to MAb KY-ANP-II among the five experimental groups and to compare differences over time in each group. Significant differences were then subjected to Neuman-Keuls post hoc analysis. A value of p<0.05 was considered significant.
Results
Twenty-five SHR-S, 20 WKY rats, and nine SHR-R were studied. Histological examination confirmed that cannulas were properly placed in the C-NTS in 21 SHR-S (10 on the 1% NaCl diet and 11 on the 8% NaCl diet), 17 WKY rats (10 on the 1% NaCl diet and seven on the 8% NaCl diet), and eight SHR-R on the 1% NaCl diet. In one SHR-S and one WKY rat, the cannula entered the cerebellum; in two SHR-S and one WKY rat, the cannula was placed in the hypoglossal nucleus.
In one SHR-S and one WKY rat, the cannula penetrated the superior cerebellar vessels; in one SHR-R, the cannula damaged NTS tissue. These four SHR-S, three WKY rats, and one SHR-R were excluded from the analysis of experimental results. Examination of 1% thionine-stained sections revealed that the extent of spread of the injectate was <200 fim (Figure 1 ). Neurons near the injection tip had normal morphology in Nissl-stained sections, indicating little damage at this site. SHR-S and SHR-R on the 1% NaCl diet had significantly higher pretreatment MAP than WKY rats on either diet at the time of study (Table 1) . High NaCl intake caused significant increases in MAP in SHR-S but not in WKY rats. There was no significant difference in MAP between SHR-S and SHR-R on the 1% NaCl Strain/diet SHR-S 1% NaCl (/i = 10) SHR-S 8% NaCl (n = ll) SHR-R 1% NaCl (n=8) WKY l%NaCl(* = 10) WKY 8% NaCl(n = 7) diet. There was no difference in pretreatment HR among the five experimental groups ( Table 1) . Microinjection of MAb KY-ANP-II into the C-NTS resulted in significant increases in MAP in SHR-S on both diets and in SHR-R on the 1% NaCl diet but not in WKY rats on either diet (Figure 2, panel A) . In SHR-S and SHR-R, the pressor responses to MAb KY-ANP-II began almost immediately after injection, reached maximal levels at 5 minutes, and returned to baseline by 40 minutes after injection. High NaCl intake did not significantly alter the pressor response to the microinjected MAb in SHR-S. There was no significant difference in the pressor response to MAb KY-ANP-II between SHR-S on either diet and SHR-R on the 1% NaCl diet. Microinjection of MAb KY-ANP-II into the C-NTS did not alter HR significantly in any diet/strain group (Figure 2, panel B) . Microinjection of control IgG into the C-NTS did not alter MAP or HR significantly in any diet/strain group (w = 3 in each group). All control IgG injections were histologically verified as being within the C-NTS.
Discussion
The present study demonstrated that microinjection of MAb KY-ANP-II into the C-NTS produced significant increases in MAP in SHR-S on either diet and in SHR-R on the 1% NaCl diet but not in WKY rats on either diet. There was no significant difference in the pressor response to the MAb among the three SHR groups. Control injection of an equal volume of IgG into the caudal NTS had no effect on MAP in any diet/strain group. These data suggest that endogenous ANP in the caudal NTS may be involved in the centrally mediated regulation of blood pressure in SHR-S and SHR-R but not in WKY rats and that this effect is independent of the NaCl sensitivity of hypertension and of dietary NaCl intake.
Previous studies have shown that ANP and its receptors are localized on cell bodies and nerve terminals in the NTS' 3 1 5 and that microinjection of ANP into NTS Time after mlcrolnjection (mln) produces significant increases in the firing rate of NTS neurons associated with reductions in arterial pressure in anesthetized Wistar rats. 16 -17 In the latter studies, the majority of ANP-responsive sites (85%) were located between 0.55 mm rostral and 1.5 mm caudal to the obex, corresponding to the site of termination of baroreceptor and chemoreceptor afferents. 17 It has also been shown that the single units excited by microinjection of ANP into NTS are excited by activation of arterial baroreceptors and inhibited by baroreceptor unloading. 17 Furthermore, studies from our own laboratory have demonstrated that administration of exogenous ANP into the C-NTS blunts the bradycardiac response to systemic administration of phenylephrine. 18 Together, these findings suggest that ANP in the NTS participates in baroreceptor reflex activation. Our observation that blockade of endogenous ANP in C-NTS with MAb KY-ANP-II caused rapid-onset pressor responses in SHR-S fed a basal NaCl diet supports this interpretation. 4 The pressor response to microinjection of the anti-ANP antibody decreased progressively in magnitude with increasing distance rostral in the NTS, suggesting that the neuronal population involved was in the baroreceptor reflex pathway.
The finding that injection of MAb KY-ANP-II into the C-NTS has a pressor effect in SHR-S and SHR-R but not in WKY rats is consistent with previous evidence that ANP stores and receptor numbers are altered in SHR compared with WKY control rats. Studies from a number of laboratories have demonstrated that the ANP content of the hypothalamus, pons, and septum is significantly elevated in SHR compared with age-matched WKY controls. 19 - 23 Furthermore, intravenous injection of ANP into the intact rat or application of ANP to brain slices in vitro causes greater increases in cGMP levels in hypothalamus and brainstem of SHR than of WKY rats.
22
- 24 Thus, levels of ANP-sensitive particulate guanylate cyclase activity in the hypothalamus and brain stem appear to be greater in SHR than in WKY rats. The NTS contains a particularly high density of ANP binding sites, 25 - 26 and NTS neurons display a significantly greater increase in cGMP after administration of ANP to slice preparations than do most other neurons in the central nervous system. 27 Although the functional significance of these alterations in endogenous brain ANP and its second messenger with respect to cardiovascular regulation has only begun to be studied, the current results lend further support to the hypothesis that the central ANP system is altered in hypertensive rats.
The location of the neurons that innervate the C-NTS remains incompletely defined. Although in the rat the nodase ganglion contains ANP, 28 -29 and ANP-positive neurons have been identified in dorsal root sensory ganglia, 30 it has yet to be demonstrated that the vagal afferents to the NTS use ANP as a neurotransmitter. Several areas that project to the NTS contain ANP immunoreactive-positive neurons, as do some NTS neurons themselves. 25 - 31 Any of these could be responsible for the effects observed in response to microinjections of ANP or MAb KY-ANP-II into the C-NTS of SHR-S, but further studies are needed to define the neuronal pathways involved.
Combined with the results of previous immunocytochemical and electrophysiological studies of ANP and its receptors in NTS, the present finding that blockade of endogenous ANP in C-NTS elicits a pressor response in the SHR is consistent with the hypothesis that NTS neurons are tonically activated by endogenous ANP in this model of hypertension. This would tend to buffer the hypertension in SHR, and the hypertension would become more severe when the ANP was removed, as by administration of an anti-ANP antibody. The absence of a pressor response to blockade of endogenous ANP in NTS of WKY rats suggests that NTS neurons are not tonically activated by ANP in the normotensive WKY rat. Tonic activation of the central baroreceptor reflex arc by ANP in the SHR could lead to blunting of baroreceptor reflex responsiveness to stimulation by volume expansion and phenylephrine infusion in SHR compared with WKY rats, 5 contributing to the central defect in the baroreceptor reflex pathway previously described in SHR. 32 The observation that the pressor responsiveness to blockade of endogenous ANP in the NTS was not altered by dietary NaCl supplementation in SHR-S is consistent with previous findings that sensitivities of the arterial and cardiopulmonary reflexes are shifted in opposite directions by dietary NaCl supplementation in this model, likely leading to no net change in overall baroreceptor reflex sensitivity. This, plus the finding that the magnitude of the pressor response to injection of anti-ANP antibody into the NTS was the same in SHR-S on both diets as in SHR-R, suggests that tonic control of blood pressure by endogenous ANP in NTS of SHR is independent of the NaCl sensitivity of hypertension and of dietary NaCl intake.
